Kira Leishear, PhD, MS

Lead Epidemiologist
Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration, United States

Disclosure information not submitted.

Presentation(s):

• Assessment of non-cardiac congenital malformations and in utero exposure to modafinil/armodafinil in the Sentinel Distributed Database

  Tuesday, August 27, 2024
  9:00 AM – 9:15 AM CEST